The group of Wang et al.—who enrolled 48 patients with advanced NSCLC treated with anti PD-(L)1 therapy—observed that blood TMB (bTMB) correlated well with tTMB calculated by WES [39]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.